… hyperglycemia (≥200 mg/dL [≥11.1 mmol/L]) with a normal fasting plasma glucose level
(<126 mg/dL [<7.0 mmol/L]) doubled the mortality risk in 3 southern hemisphere populations. …

… Avignon A, Radauceanu A, Monnier L: Nonfasting plasma glucose is a better marker of
diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822–1826, …

Glycaemic variability is an integral component of glucose homoeostasis. Although it has not
yet been definitively confirmed as an independent risk factor for diabetes complications, …

… /L]), as obtained from the continuous glucose monitoring system, is not comparable with the
mean plasma glucose concentration (261 mg/dL [14.5 mmol/L… /dL (1.05 mmol/L) between the …

… /l (110 mg/dl), reflecting the increases in both fasting and postprandial PG. The baseline value
of 6.1 mmol/l … Monnier L: Is postprandial glucose a neglected cardiovascular risk factor in …

Background Risk stratification and therapeutic decision-making for myelodysplastic
syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), …

OBJECTIVE— The aim of the study was to determine whether the loss of fasting and postprandial
glycemic control occurs in parallel or sequentially in the evolution of type 2 diabetes. …

OBJECTIVE To evaluate the relative value of plasma glucose (PG) at different time points in
assessing glucose control of type 2 diabetic patients. RESEARCH DESIGN AND METHODS …

Background Good results obtained after laparoscopic sleeve gastrectomy (LSG), in terms of
weight loss and morbidity, have been reported in few recent studies. Our team has designed …

… Finally, the interstitial glucose value of 56 mg/dL (3.1 mmol/L), which was selected as the …
/L) corresponded approximately to a plasma glucose concentration of 70 mg/dL (3.9 mmol/L). …